# Yaowumuchang raises USD 55 million in Series D financing

On 2026-07-13, according to Xiniu Data, Yaowumuchang completed Series D financing, raising USD 55 million. Investors were lead investor Pudong Venture Capital Group, participating investor Zhikai Capital, participating investor Shenzhen City Luohudonghairuizhi Pharmaceutical Industrial Investment Partnership (Limited Partnership), participating investor Keyuanzhiyao, participating investor Baiaoweida, participating investor YD Capital, participating investor Jiashanguotou, participating investor Detong Capital, participating investor Weidu Capital, participating investor Biometas. The company is a novel drug developer.



Canonical: https://uniquebase.ai/news/927bfe6f-29c5-4b26-a5e5-890b14f93377
Stable identifier: 927bfe6f-29c5-4b26-a5e5-890b14f93377
Snapshot captured: 2026-10-20T18:19:32.670Z
English updated: 2026-10-20T18:31:05.607Z

## Connected profiles

- [Baiaoweida](/institutions/baiaoweida)
- [Biometas](/institutions/biometas)
- [Detong Capital](/institutions/detong-capital)
- [Jiashanguotou](/institutions/jiashanguotou)
- [Keyuanzhiyao](/institutions/keyuanzhiyao)
- [Pudong Venture Capital Group](/institutions/pudong-venture-capital-group)
- [Shenzhen City Luohudonghairuizhi Pharmaceutical Industrial Investment Partnership (Limited Partnership)](/institutions/shenzhen-city-luohudonghairuizhi-pharmaceutical-industrial-investment-partnership-limited-partnership)
- [Weidu Capital](/institutions/weidu-capital)
- [YD Capital](/institutions/yd-capital)
- [Yaowumuchang](/companies/UB-C10541)
- [Zhikai Capital](/institutions/zhikai-capital)

## Sources

- No source links are available for this profile.